Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Pharmaceutical Lipid-Based Excipients Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The market size for pharmaceutical lipid-based excipients has shown strong growth in recent years. This market is projected to expand from $1.77 billion in 2025 to $1.86 billion in 2026, at a compound annual growth rate (CAGR) of 5.2%. Historically, this growth can be attributed to factors such as the increasing number of poorly water-soluble drug pipelines, advancements in lipid formulation science, the expansion of pharmaceutical manufacturing, the rising adoption of oral delivery systems, and regulatory support for lipid excipients.
The pharmaceutical lipid-based excipients market is anticipated to show robust growth over the next few years, projected to reach $2.29 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This expansion during the forecast period is attributable to several factors, including an increase in complex drug formulations, a rising demand for improved drug absorption, the expanding use of biologics and oncology drugs, ongoing advancements in lipid technologies, and a growing emphasis on patient-centric formulations. Furthermore, significant trends expected within this period involve the increasing application of lipid excipients for poorly soluble drugs, their broader adoption in both oral and parenteral formulations, a heightened demand for bioavailability-enhancing excipients, the wider deployment of lipid-based drug delivery systems, and an increasing focus on natural and sustainable lipids.
Get A Free Sample Report With In-Depth Market Insights:
Pharmaceutical Lipid-Based Excipients Market Demand Drivers Opening New Revenue Streams
The increasing adoption of gene therapy is anticipated to boost the expansion of the pharmaceutical lipid-based excipients market in the future. Gene therapy refers to a medical method focused on altering or manipulating an individual’s genes to address or avert illnesses. This increase in gene therapy is attributed to improvements in delivery systems, which allow for the secure, effective, and precise delivery of genetic material into cells. Pharmaceutical lipid-based excipients augment gene therapy by facilitating effective delivery systems and guaranteeing the stability and targeted movement of genetic material. These excipients contribute to better therapeutic results by safeguarding nucleic acids and aiding cellular absorption, thereby enhancing the efficacy of contemporary treatments. As an illustration, in December 2024, data from the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, indicated that the Food and Drug Administration (FDA) sanctioned 6 gene therapy products in 2023, an increase from five approvals recorded in 2022. Consequently, the growing prevalence of gene therapy is fueling the expansion of the pharmaceutical lipid-based excipients market.
Pharmaceutical Lipid-Based Excipients Market Segments: Where Is Growth Concentrated?
The pharmaceutical lipid-based excipients market covered in this report is segmented –
1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types
2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications
3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications
4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)
5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users
Subsegments:
1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils
2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils
3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC
4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats
5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs
6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids
7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate
8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides
9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids
Pharmaceutical Lipid-Based Excipients Market Trends Powering Strategic Industry Growth
Major companies in the pharmaceutical lipid-based excipients market are concentrating on strategic investments, such as developing advanced Centers of Excellence. These efforts aim to drive innovation, enhance formulation capabilities, support drug delivery research, and reinforce their competitive position across emerging therapeutic areas. For instance, in November 2024, Gattefossé SAS, a France-based chemical manufacturing company, opened a cutting-edge Technical Center of Excellence in Mumbai. This facility is designed to support India’s growing pharma market by offering specialized labs and tailored assistance for excipient innovation, with a particular focus on bioavailability, sustained release, and topical formulations, while simultaneously strengthening its presence in the Asia-Pacific region. The state-of-the-art facility includes pharmaceutical and personal care application laboratories, intended to foster innovation, encourage collaboration, and provide a productive work environment.
Pharmaceutical Lipid-Based Excipients Market Key Participants And Competitive Landscape
Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth
View The Full Pharmaceutical Lipid-Based Excipients Market Report:
Pharmaceutical Lipid-Based Excipients Market Leading Geography: Which Region Contributes The Most Revenue?
Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model